Welcome to our dedicated page for Optimizerx news (Ticker: OPRX), a resource for investors and traders seeking the latest updates and insights on Optimizerx stock.
OptimizeRx Corporation reports developments in healthcare technology for life sciences marketing, with updates centered on tools that connect pharmaceutical brands with healthcare professionals and patients. The company’s platform uses EHR-based access, omnichannel activation, the Dynamic Audience Activation Platform, and Micro-Neighborhood audiences to support HCP and direct-to-consumer engagement.
Recurring OptimizeRx news includes product and network launches, programmatic access to EHR advertising, privacy-safe identity resolution collaborations, quarterly and annual results, debt and share-repurchase actions, and board or leadership changes. Coverage also reflects the company’s focus on privacy-compliant audience targeting and campaign measurement across healthcare marketing channels.
OptimizeRx reported a substantial year-over-year growth for Q1 2024, with revenue increasing by 51% to $19.7 million and gross profit rising by 64% to $12.2 million, representing a 62% gross margin. Despite these gains, the company faced a GAAP net loss of $6.9 million or $0.38 per share, slightly higher than the $6.4 million loss in Q1 2023. Non-GAAP net loss also increased to $2.0 million or $0.11 per share. Adjusted EBITDA improved to a loss of $0.3 million from $2.2 million in Q1 2023. The company secured 9 additional DAAP deals and reported having $15.2 million in cash and equivalents. The firm reaffirmed its 2024 guidance, expecting at least $100 million in revenue and $11 million in adjusted EBITDA. Key performance indicators showed positive trends, with net revenue retention at 116% and revenue per full-time employee at $641,000.
OptimizeRx Corp. (OPRX) is set to participate in several investor conferences including the RBC Capital Markets Global Healthcare Conference, B.Riley Securities Institutional Investor Conference, Stifel Cross Sector Insight Conference, William Blair Annual Growth Stock Conference, and Citizens JMP Medical Devices and Healthcare Services Forum. This move aims to enhance engagement with healthcare professionals and patients, showcasing the company's commitment to innovative healthcare technology solutions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.